QQQ   355.23 (+0.59%)
AAPL   182.14 (+0.87%)
MSFT   328.46 (+0.98%)
META   265.35 (+0.29%)
GOOGL   123.02 (+0.72%)
AMZN   124.48 (+0.19%)
TSLA   247.21 (+5.26%)
NVDA   391.41 (+1.64%)
NIO   7.82 (+0.39%)
BABA   85.91 (-0.27%)
AMD   125.64 (+3.79%)
T   16.02 (-0.31%)
F   13.80 (+1.62%)
MU   65.59 (+0.41%)
CGC   0.67 (-4.02%)
GE   106.01 (-0.06%)
DIS   91.97 (-0.61%)
AMC   4.75 (+1.50%)
PFE   38.94 (-0.38%)
PYPL   63.75 (-0.76%)
NFLX   423.29 (+3.40%)
QQQ   355.23 (+0.59%)
AAPL   182.14 (+0.87%)
MSFT   328.46 (+0.98%)
META   265.35 (+0.29%)
GOOGL   123.02 (+0.72%)
AMZN   124.48 (+0.19%)
TSLA   247.21 (+5.26%)
NVDA   391.41 (+1.64%)
NIO   7.82 (+0.39%)
BABA   85.91 (-0.27%)
AMD   125.64 (+3.79%)
T   16.02 (-0.31%)
F   13.80 (+1.62%)
MU   65.59 (+0.41%)
CGC   0.67 (-4.02%)
GE   106.01 (-0.06%)
DIS   91.97 (-0.61%)
AMC   4.75 (+1.50%)
PFE   38.94 (-0.38%)
PYPL   63.75 (-0.76%)
NFLX   423.29 (+3.40%)
QQQ   355.23 (+0.59%)
AAPL   182.14 (+0.87%)
MSFT   328.46 (+0.98%)
META   265.35 (+0.29%)
GOOGL   123.02 (+0.72%)
AMZN   124.48 (+0.19%)
TSLA   247.21 (+5.26%)
NVDA   391.41 (+1.64%)
NIO   7.82 (+0.39%)
BABA   85.91 (-0.27%)
AMD   125.64 (+3.79%)
T   16.02 (-0.31%)
F   13.80 (+1.62%)
MU   65.59 (+0.41%)
CGC   0.67 (-4.02%)
GE   106.01 (-0.06%)
DIS   91.97 (-0.61%)
AMC   4.75 (+1.50%)
PFE   38.94 (-0.38%)
PYPL   63.75 (-0.76%)
NFLX   423.29 (+3.40%)
QQQ   355.23 (+0.59%)
AAPL   182.14 (+0.87%)
MSFT   328.46 (+0.98%)
META   265.35 (+0.29%)
GOOGL   123.02 (+0.72%)
AMZN   124.48 (+0.19%)
TSLA   247.21 (+5.26%)
NVDA   391.41 (+1.64%)
NIO   7.82 (+0.39%)
BABA   85.91 (-0.27%)
AMD   125.64 (+3.79%)
T   16.02 (-0.31%)
F   13.80 (+1.62%)
MU   65.59 (+0.41%)
CGC   0.67 (-4.02%)
GE   106.01 (-0.06%)
DIS   91.97 (-0.61%)
AMC   4.75 (+1.50%)
PFE   38.94 (-0.38%)
PYPL   63.75 (-0.76%)
NFLX   423.29 (+3.40%)
NASDAQ:TRIB

Trinity Biotech (TRIB) Competitors

$1.07
+0.03 (+2.88%)
(As of 01:59 PM ET)
Compare
Today's Range
$1.01
$1.08
50-Day Range
$0.84
$1.14
52-Week Range
$0.80
$1.50
Volume
51,765 shs
Average Volume
32,555 shs
Market Capitalization
$40.78 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

TRIB vs. NYMX, OCX, ICCC, AWH, BMRA, CDIO, MYMD, TKNO, ACHV, and PLUR

Should you be buying Trinity Biotech stock or one of its competitors? The main competitors of Trinity Biotech include Nymox Pharmaceutical (NYMX), OncoCyte (OCX), ImmuCell (ICCC), Aspira Women's Health (AWH), Biomerica (BMRA), Cardio Diagnostics (CDIO), MyMD Pharmaceuticals (MYMD), Alpha Teknova (TKNO), Achieve Life Sciences (ACHV), and Pluri (PLUR). These companies are all part of the "medical" sector.

Trinity Biotech vs.

Nymox Pharmaceutical (NASDAQ:NYMX) and Trinity Biotech (NASDAQ:TRIB) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, media sentiment, valuation, earnings, analyst recommendations, profitability, risk, community ranking and dividends.

Nymox Pharmaceutical has higher earnings, but lower revenue than Trinity Biotech. Nymox Pharmaceutical is trading at a lower price-to-earnings ratio than Trinity Biotech, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nymox PharmaceuticalN/AN/A-$6.58 million-$0.04-9.98
Trinity Biotech$74.78 million0.53-$41.01 million-$1.29-0.81

0.8% of Nymox Pharmaceutical shares are held by institutional investors. Comparatively, 18.4% of Trinity Biotech shares are held by institutional investors. 54.0% of Nymox Pharmaceutical shares are held by insiders. Comparatively, 8.2% of Trinity Biotech shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Trinity Biotech received 127 more outperform votes than Nymox Pharmaceutical when rated by MarketBeat users. Likewise, 68.06% of users gave Trinity Biotech an outperform vote while only 51.55% of users gave Nymox Pharmaceutical an outperform vote.

CompanyUnderperformOutperform
Nymox PharmaceuticalOutperform Votes
150
51.55%
Underperform Votes
141
48.45%
Trinity BiotechOutperform Votes
277
68.06%
Underperform Votes
130
31.94%

Nymox Pharmaceutical has a net margin of 0.00% compared to Trinity Biotech's net margin of -54.84%. Trinity Biotech's return on equity of -724.07% beat Nymox Pharmaceutical's return on equity.

Company Net Margins Return on Equity Return on Assets
Nymox Pharmaceutical N/A -1,589.50% -117.25%
Trinity Biotech -54.84% -724.07% -25.12%

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Nymox Pharmaceutical
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Trinity Biotech
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Nymox Pharmaceutical has a beta of 0.82, suggesting that its share price is 18% less volatile than the S&P 500. Comparatively, Trinity Biotech has a beta of 1.41, suggesting that its share price is 41% more volatile than the S&P 500.

In the previous week, Trinity Biotech had 3 more articles in the media than Nymox Pharmaceutical. MarketBeat recorded 3 mentions for Trinity Biotech and 0 mentions for Nymox Pharmaceutical. Trinity Biotech's average media sentiment score of 0.43 beat Nymox Pharmaceutical's score of 0.00 indicating that Trinity Biotech is being referred to more favorably in the news media.

Company Overall Sentiment
Nymox Pharmaceutical Neutral
Trinity Biotech Neutral

Summary

Trinity Biotech beats Nymox Pharmaceutical on 10 of the 14 factors compared between the two stocks.


New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TRIB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TRIB vs. The Competition

MetricTrinity BiotechDiagnostic substances IndustryMedical SectorNASDAQ Exchange
Market Cap$40.77M$2.31B$4.57B$6.28B
Dividend YieldN/A0.79%2.37%6.18%
P/E Ratio-0.8323.8697.2212.24
Price / Sales0.5557.623,291.5988.59
Price / CashN/A4,431.7991.54113.47
Price / Book-17.835.884.685.30
Net Income-$41.01M$28.14M$117.79M$192.86M
7 Day Performance9.17%-0.26%1.03%1.66%
1 Month Performance6.99%1.66%1.64%5.31%
1 Year Performance-20.16%-10.22%8.52%3.20%

Trinity Biotech Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NYMX
Nymox Pharmaceutical
0 of 5 stars
$0.41
+2.5%
N/A-6.5%$36.90MN/A-10.193Analyst Report
OCX
OncoCyte
2.2845 of 5 stars
$0.23
+4.6%
$1.11
+388.2%
N/A$37.56M$875,000.000.00N/AAnalyst Report
ICCC
ImmuCell
0 of 5 stars
$5.09
-1.0%
N/A-39.3%$39.45M$18.57M-7.3860
AWH
Aspira Women's Health
1.5741 of 5 stars
$2.78
-7.0%
$30.00
+979.1%
-73.3%$23.16M$8.18M-0.2185Analyst Report
BMRA
Biomerica
0 of 5 stars
$1.30
+0.8%
N/A-60.5%$21.85M$18.87M-2.4166
CDIO
Cardio Diagnostics
1.9939 of 5 stars
$1.35
-6.9%
$8.00
+492.6%
N/A$13.09M$950.000.00N/A
MYMD
MyMD Pharmaceuticals
0 of 5 stars
$1.61
-3.0%
N/A-41.8%$63.55MN/A-4.476Upcoming Earnings
TKNO
Alpha Teknova
2.3976 of 5 stars
$3.90
-0.5%
$9.33
+139.3%
-50.6%$110.06M$41.42M-2.17237Positive News
ACHV
Achieve Life Sciences
2.0345 of 5 stars
$6.28
-2.6%
$18.67
+197.2%
-12.4%$113.30MN/A-1.6716
PLUR
Pluri
0 of 5 stars
$0.89
+11.3%
N/AN/A$36.60M$176,000.000.00N/AUpcoming Earnings
Gap Up
High Trading Volume

Related Companies and Tools

This page (NASDAQ:TRIB) was last updated on 6/9/2023 by MarketBeat.com Staff

My Account -